Highlights in liver transplantation
23 February 2006
23 February 2006
Mark Siegler, Mary C. Simmerling, Jessica H. Siegler, David C. Cronin – 23 February 2006
Todd H. Baron – 23 February 2006
Zun Chang Liu, Thomas Ming Swi Chang – 22 February 2006 – Under specific conditions, bone marrow cells can transdifferentiate into a variety of cell types including hepatocytes. In this study, bioencapsulated bone marrow cells were transplanted intraperitoneally into 90% hepatectomized rats. We then followed the transdifferentiation of the bone marrow cells and the effect of this on liver regeneration in this liver failure model. Bone marrow cells isolated from Wistar rats were bioencapsulated using alginate‐polylysine‐alginate method.
Andreas Untergasser, Uta Zedler, Anja Langenkamp, Marianna Hösel, Maria Quasdorff, Knud Esser, Hans‐Peter Dienes, Barbara Tappertzhofen, Waldemar Kolanus, Ulrike Protzer – 22 February 2006 – Dendritic cells (DC) of hepatitis B virus (HBV) carriers have been reported to exhibit functional impairment. Possible explanations for this phenomenon are infection of HBV by DC or alteration of DC function by HBV.
Margaret James Koziel – 22 February 2006
Jared D. Evans, Christoph Seeger – 22 February 2006 – Antiviral immunity against a pathogen is mounted upon recognition by the host of virally associated structures.
Paul B. Watkins, Leonard B. Seeff – 22 February 2006 – Idiosyncratic drug induced liver injury (DILI) remains poorly understood. It is assumed that the affected individuals possess a rare combination of genetic and non genetic factors that, if identified, would greatly improve understanding of the underlying mechanisms. This single topic conference brought together basic scientists, translational investigators, and clinicians with an interest in DILI.
Xiaoling Jin, Teresa A. Zimmers, Eduardo A. Perez, Robert H. Pierce, Zongxiu Zhang, Leonidas G. Koniaris – 22 February 2006 – Interleukin‐6 (IL‐6) is an important mediator of liver regeneration and repair that is also elevated in chronic liver diseases, including fatty liver of obesity and cirrhosis. IL‐6 has been reported both to delay and accelerate liver regeneration.
Thomas D. Boyer – 22 February 2006